Diagnosis and Management of Central Nervous System Metastases from Breast Cancer, The Oncologist, vol.8, issue.5, pp.398-410, 2003. ,
DOI : 10.1634/theoncologist.8-5-398
Brain metastases, CNS metastases in breast cancer, pp.1-23, 2003. ,
DOI : 10.1016/S0733-8619(02)00035-X
Brain metastases in breast cancer; natural history, prognostic factors and outcome, Journal of Neuro-Oncology, vol.6, issue.2, pp.165-174, 1993. ,
DOI : 10.1007/BF01053937
The natural history of breast cancer patients with brain metastases, Cancer, vol.2, issue.5, pp.1913-1918, 1979. ,
DOI : 10.1002/1097-0142(197911)44:5<1913::AID-CNCR2820440554>3.0.CO;2-D
Brain metastases from breast cancer: clinical course, prognosis and influence of treatment, Clin Oncol, vol.7, issue.4, pp.291-301, 1981. ,
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma, Cancer, vol.12, issue.12, pp.972972-2977, 2003. ,
DOI : 10.1002/cncr.11436
Increased Rate of Brain Metastasis with Trastuzumab Therapy Not Associated with Impaired Survival, Clinical Breast Cancer, vol.4, issue.2, pp.114-119, 2003. ,
DOI : 10.3816/CBC.2003.n.016
Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment, European Journal of Cancer, vol.40, issue.3 ,
DOI : 10.1016/j.ejca.2003.09.018
Her-2 Overexpression Increases the Metastatic Outgrowth of Breast Cancer Cells in the Brain, Cancer Research, vol.67, issue.9, pp.4190-4198, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-3316
Potassium channel induction by the Ras/Raf signal transduction cascade ,
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas, Cancer Res, issue.9, pp.613826-3836, 2001. ,
Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau protein, J Physiol, issue.2, pp.571349-359, 2006. ,
Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis, International Journal of Cancer, vol.3, issue.2, pp.365-371, 2008. ,
DOI : 10.1002/ijc.23511
URL : https://hal.archives-ouvertes.fr/hal-00347966
Blood-brain barrier-specific properties of a human adult brain endothelial cell line, The FASEB Journal, issue.13, pp.191872-1874, 2005. ,
DOI : 10.1096/fj.04-3458fje
Regulation of Blood-Brain Tumor Barrier Permeability by Calcium-Activated Potassium Channels, Journal of Pharmacology and Experimental Therapeutics, vol.301, issue.3, pp.838-851, 2002. ,
DOI : 10.1124/jpet.301.3.838
Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration, Clinical and Developmental Immunology, vol.58, issue.2, p.384982, 2008. ,
DOI : 10.1152/ajpcell.00172.2004
Enhancement ofin vitro tumor???cell transcellular migration by tumor???cell???secreted endothelial???cell???retraction factor, International Journal of Cancer, vol.79, issue.1 ,
DOI : 10.1002/ijc.2910630120
Genes that mediate breast cancer metastasis to lung, Nature, vol.436, issue.7050, pp.436518-524, 2005. ,
DOI : 10.1038/nature03799
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283098
A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, vol.3, issue.6, pp.537-549, 2003. ,
DOI : 10.1016/S1535-6108(03)00132-6
Increased leukotriene C4 and vasogenic edema surrounding brain tumors in humans, Annals of Neurology, vol.59, issue.6, pp.592-595, 1986. ,
DOI : 10.1002/ana.410190613
Bradykinin Selectively Opens Blood-Tumor Barrier in Experimental Brain Tumors, Journal of Cerebral Blood Flow & Metabolism, vol.51, issue.5, pp.862-870, 1994. ,
DOI : 10.1038/jcbfm.1994.108
Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors, Cancer Res, vol.58, issue.5, pp.914-920, 1998. ,
Ion Channels and Amino Acid Transporters Support the Growth and Invasion of Primary Brain Tumors, Molecular Neurobiology, vol.29, issue.1, pp.61-71, 2004. ,
DOI : 10.1385/MN:29:1:61
Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene, Cancer Cell, vol.3, issue.3, pp.297-302, 2003. ,
DOI : 10.1016/S1535-6108(03)00054-0
Calcium-activated potassium channels, Current Opinion in Neurobiology, vol.8, issue.3, pp.321-329, 1998. ,
DOI : 10.1016/S0959-4388(98)80056-1
From The Cover: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival, Proceedings of the National Academy of Sciences, vol.102, issue.10, pp.1023738-3743, 2005. ,
DOI : 10.1073/pnas.0409462102
Tight junctions of the blood???brain barrier, Vascular Pharmacology, vol.38, issue.6, pp.323-337, 2002. ,
DOI : 10.1016/S1537-1891(02)00200-8